March 19, 2020 News by Catarina Silva More Attention Should Be Given to MS Patients’ Sexual Dysfunction, Study Advises Sexual dysfunction is prevalent among women with multiple sclerosis (MS), and one way physicians can help improve their patients’ quality of life is to ask them about the problem. That finding is detailed in the study “Sexual dysfunction in women with multiple sclerosis: prevalence and impact on…
March 9, 2020 News by Catarina Silva Final Site Announced in Phase 2 Trial Testing NurOwn in Progressive MS The Partners Multiple Sclerosis Center at Brigham and Women’s Hospital has joined BrainStorm Cell Therapeutics in a Phase 2 trial exploring the safety and efficacy of NurOwn in the treatment of progressive multiple sclerosis (MS). This is the fifth and final clinical site participating in…
February 18, 2020 News by Catarina Silva Incontinence in MS Affects Walking Ability, Negatively Impacts Patients’ Quality of Life, Study Finds Urinary incontinence, associated with poor functioning of the muscles in the pelvic area, was found to have a negative impact on daily activities like walking and overall quality of life in people with multiple sclerosis (MS), a study shows. Adding pelvic floor muscle training to an MS…
January 10, 2020 News by Catarina Silva Vitalis Plans to Launch Phase 3 Trial Testing VTS-72 as Treatment for RRMS-related Flushing Vitalis will soon test VTS-72, a new formulation of fumarate and VTS-Aspirin, in a Phase 3 trial as a treatment for flushing — facial redness, itching or rash — in patients with relapsing-remitting multiple sclerosis (RRMS). Flushing is a common side effect of an oral MS therapy called…
January 8, 2020 News by Catarina Silva Using Interferon-beta While Pregnant Does Not Influence Child Size at Birth, MS Study Finds Treatment with interferon-beta therapy during pregnancy in women with multiple sclerosis (MS) does not influence children’s gestational age, birth weight, length, or head size, researchers report. The study with those findings, “The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with…
December 4, 2019 News by Catarina Silva CMSC Joins NeurologyLive Program for Specialists Caring for Those with MS, Like Diseases NeurologyLive, a platform for healthcare specialists, has added The Consortium of Multiple Sclerosis Centers (CMSC) to its Strategic Alliance Partnership program that works to share insights and experiences to benefit people with multiple sclerosis (MS) and their families. A collaborative mix of neurological centers, networks, and…
August 23, 2018 News by Catarina Silva MS Patients Speak of Importance of Exercise and Activity to Overall Sense of Well-Being in UK Study People with multiple sclerosis (MS) value exercise and physical activity far beyond the concept of “staying fit,” and consider exercise essential to maintaining a reasonable level of independence and being able to engage in social activities, a small U.K. study based on interviews reports. The study, “…
May 2, 2018 News by Catarina Silva Members of Canadian Parliament Commemorate MS Awareness Month Members of Parliament and the Multiple Sclerosis Society of Canada are jointly celebrating May as Multiple Sclerosis (MS) Awareness Month. Both parties met in Ottawa April 30-May 2 to kick-off the MS awareness campaign #LifeWithMs. According to an international survey, it is estimated that one in every 340 Canadians…
February 26, 2018 News by Catarina Silva Epstein-Barr Virus Found in Brain Cells of Many MS Patients, Study Reports United Arab Emirates scientists have found active Epstein-Barr virus in many multiple sclerosis patients’ brain cells, supporting the notion that it plays a role in the disease. The team found it in two types of brain cells — astrocytes and microglia. The virus can be active or lie dormant in…
December 22, 2017 News by Catarina Silva Britain’s National Health Service Likely to Cover the Multiple Sclerosis Therapy Extavia Britain’s National Health Service should cover the multiple sclerosis therapy Extavia, the National Institute for Health and Care Excellence (NICE) has recommended. The health service usually follows the institute’s recommendations. So NICE’s endorsement means there is a good chance the health service will begin covering the Extavia prescriptions that…